Summary of studies about the expressional changes of APLN and APELA in the polycystic ovary syndrome (PCOS), Ovarian cancer (OvCa), preeclampsia (PE) and gestational diabetes mellitus (GDM). This evidence concerns the gene APLN and polycystic ovary syndrome.